Estrogen and progesterone receptor expression

An immunohistochemical study of endometrial lesions in perimenopausal age group

https://doi.org/10.53730/ijhs.v6nS2.8044

Authors

  • S. Manjani Associate Professor, Department of Pathology Bhaarath Medical College and Hospital (BIHER)
  • M. Vijayamalathi Associate Professor, Department of Physiology, Bhaarath Medical College and Hospital (BIHER)
  • S. Sree Ranjini Professor & HOD, Department of Anaesthesiology, Bhaarath Medical College and Hospital (BIHER)
  • C. S. Janaki Associate Professor, Department of Anatomy, Bhaarath Medical College and Hospital (BIHER)
  • C. S. Arulparithi Associate professor, Department of Paediatrics, Vinayaga Mission Medical College, Karaikal

Keywords:

AUB, estrogen receptor, progesterone receptor

Abstract

Background:  The common gynaecological complaints encountered is dysfunctional uterine bleeding .Pipelle aspiration & Dilatation and curettage is done to find out the Histomorphological and its immunohistochemical alterations . Objective : This study  aims to bring out the expression of  Estrogen and Progesterone receptor in perimenopausal women  of  non-malignant and malignant endometrium presenting with menorrhagia. Result: Endometrial samples of 41 Perimenopausal women with AUB were also subjected to immunohistochemical staining to find out the Estrogen and Progesterone receptor status. Immunohistochemistry revealed the mean of PI values for ER and PR were highest in the proliferative endometrium (91.64% for ER; 94.38% for PR) followed by simple hyperplasia, complex hyperplasia, atypical hyperplasia and endometrial carcinoma (27.5% for ER; 27% for PR). Conclusion: Immunohistochemistry results in perimenopausal women show that the estrogen and progesterone receptor expression decreases progressively from proliferative endometrium to hyperplasias to endometrial carcinoma.

Downloads

Download data is not yet available.

References

Ayman A A Ewies, Kadry A A Shaaban, Reena Merard, Ulises Zanetto. Endometrial biopsy in women with abnormal uterine bleeding: inadequate and unassessable categorisation is not clinically relevant. J Clin Pathol, 67 (2014), 673-677.

Kennedy MM, Baigrie CF, Manek S. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT related and non-HRT related endometrial pathology. Int J Gynecol Pathol, 18 (1999), 130-137.

Ferenczy, Alex. Pathophysiology of endometrial bleeding. Maturitas The European Menopause Journal , 45 (2003), 1-14.

Jonathan S. Berek, MD, MMS, Neville F. Hacker, AM, MD. Berek & Hacker’s Gynecologic Oncology. 2015.

Robert J. Kurman, Richard W. TeLinde. Blaustein’s Pathology of the Female Genital Tract. 2011.

I. Mylonas, U. Jeschke, N. Shabani, C. Kuhn, S. Kriegel, M. S. KUPKA And K. Friese. Normal and Malignant Human Endometrium Express Immunohistochemically Estrogen Receptor Alpha (ER α), Estrogen Receptor Beta (ER β) and Progesterone Receptor (PR). Anticancer Research, 25 (2005), 1679-1686.

Daniela Ilie, claudia Valentina Georgescu, Cristiana Simionescu, Anca Daniela Braila, M. Braila. Immunohistochemical Aspects of Endometrium Hyperplasias in Perimenopause. Current Health Sciences Journal, 37, 2 (2011).

Sahar Aly Daoud, Hala Naguib Hosni and Amal Ahmed Hareedy. Immunohistochemical Expressions of ER, PR and ALDH1 in Endometrial Hyperplasia and Carcinoma. Journal of American Science, 9, 12 (2013).

Published

28-05-2022

How to Cite

Manjani, S., Vijayamalathi, M., Ranjini, S. S., Janaki, C. S., & Arulparithi, C. S. (2022). Estrogen and progesterone receptor expression: An immunohistochemical study of endometrial lesions in perimenopausal age group. International Journal of Health Sciences, 6(S2), 11336–11342. https://doi.org/10.53730/ijhs.v6nS2.8044

Issue

Section

Peer Review Articles